Document Detail


Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.
MedLine Citation:
PMID:  23381549     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Notwithstanding the considerable advances in the treatment options for schizophrenia, the cognitive symptoms in particular are not receptive to antipsychotic treatment and considered one of the main predictors for poor social and functional outcome of the disease. Recent findings in preclinical model systems indicate that epigenetic modulation might emerge as a promising target for the treatment of cognitive disorders. The aim of this review is to introduce some of the principles of chromatin biology to the reader and to discuss a possible role in the neurobiology and pathophysiology of schizophrenia. We will discuss potential epigenetic targets for drug therapy, including histone deacetylase inhibitors (HDACi). In a second part, conceptual and practical challenges associated with clinical trials of chromatin-modifying drugs in psychiatric patient populations are discussed, including safety profiles, the potential for adverse effects and general issues revolving around pharmacokinetics and pharmacodynamics. Additional investigations are required in order to fully evaluate the potential of HDACi and similar "epigenetic therapies" as novel treatment options for schizophrenia and other psychotic disease.
Authors:
Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Related Documents :
23896259 - A 10-year follow-up of a population-based study of people with multiple sclerosis in st...
21875209 - The effects of expressive writing following first myocardial infarction: a randomized c...
24117909 - No pain, no gain: depressed clients' experiences of cognitive behavioural therapy.
10360409 - When the cradle falls: the treatment of postnatal depression in a psychiatric day hospi...
2405339 - Depression in children.
24525659 - The selective neurokinin 3 antagonist azd2624 does not improve symptoms or cognition in...
11173169 - Effects of urine testing frequency on outcome in a methadone take-home contingency prog...
3312179 - Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of da...
18301269 - Enteral feeding.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-5
Journal Detail:
Title:  European archives of psychiatry and clinical neuroscience     Volume:  -     ISSN:  1433-8491     ISO Abbreviation:  Eur Arch Psychiatry Clin Neurosci     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9103030     Medline TA:  Eur Arch Psychiatry Clin Neurosci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Deparment of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Nussbaumstr. 7, 80336, Munich, Germany, ahasan@gwdg.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain volumes differ between diagnostic groups of violent criminal offenders.
Next Document:  Gene expression profiling of granulosa cells from PCOS patients following varying doses of human cho...